Beta-Defensin 2 vs Omiganan — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Human beta-defensin 2 (HBD-2) is an inducible antimicrobial peptide expressed by skin keratinocytes, respiratory epithelium, and gut epithelium in response to microbial infection and pro-inflammatory cytokines. Unlike the constitutively expressed HBD-1, HBD-2 expression is strong...
Calculate Beta-Defensin 2 dose →Omiganan (CLS001, MBI-226) is a synthetic analog of indolicidin, a bovine neutrophil AMP. It was developed for topical antimicrobial applications including acne vulgaris, catheter-site infection prevention, and rosacea....
Calculate Omiganan dose →| Parameter | Beta-Defensin 2 | Omiganan |
|---|---|---|
| Category | Antimicrobial Peptide | Antimicrobial Peptide |
| Research | Preclinical | Phase 3 (Completed) |
| Half-Life | Hours (in tissues) | Hours (topical) |
| Typical Dose | N/A | 1-3% gel |
| Frequency | N/A | Twice daily |
| Route | Endogenous (inducible epithelial) / Topical (research) | Topical gel/cream |
| FDA Status | Not approved | Not approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.